Veritas In Silico

Tokyo, Japan

Veritas In Silico is a research and sales of pharmaceuticals firm that offers drug discovery platform technology with scientific evidences.

Dec 2021

Series C

Business Information Systems Cloud Data Services Pharmaceutical

Top Investors

Mitsubishi UFJ Capital Mizuho Capital SMBC Venture Capital Global Brain Corporation Nippon Venture Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Veritas In Silico

Who are Veritas In Silico's investors?

Veritas In Silico's investors include Mitsubishi UFJ Capital, Mizuho Capital, SMBC Venture Capital, Global Brain Corporation, Nippon Venture Capital.

Where is Veritas In Silico headquartered?

Veritas In Silico is headquartered in Tokyo, Japan.

What does Veritas In Silico do?

Veritas In Silico is a research and sales of pharmaceuticals firm that offers drug discovery platform technology with scientific evidences.

What stage is Veritas In Silico at?

Veritas In Silico is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 27, 2021.

MLA

"Veritas In Silico — Funding & Investors." VCBacked, December 27, 2021, https://www.vcbacked.co/company/veritas-in-silico. Accessed July 1, 2026.

APA

VCBacked. (2021). Veritas In Silico — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/veritas-in-silico

Wikipedia (cite web)

{{cite web |title=Veritas In Silico — Funding & Investors |url=https://www.vcbacked.co/company/veritas-in-silico |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 27, 2021.

Similar Companies in Business Information Systems